Valuable isotope used in quantum computing, neutron research, border security and medical imaging Toronto, ON – Laurentis Energy Partners today announced a long-term commercial agreement with Air Liquide for the distribution of Helium-3 (He-3), a rare isotope used in quantum computing, neutron
One of the most prevalently used diagnostic imaging agents in nuclear medicine, helping to detect illnesses like cancer and heart disease Clarington, Ontario – A new program, led by Laurentis Energy Partners and BWXT Medical Ltd. (BWXT Medical), to produce the
November 2, 2021: Today in the Ontario legislature, a Private Member’s motion introduced by Bruce-Grey-Owen Sound MPP Bill Walker passed with all party support. The motion asserted Ontario’s global role as a leader in the supply of medical isotopes to
TORONTO – October 27, 2021 – Laurentis Energy Partners, an innovator and leader in the clean-energy industry, has joined the Canadian Nuclear Isotope Council (CNIC). Laurentis Energy Partners offers expertise in nuclear, hydro, and solar generation, inspections and engineering, nuclear
October 26, 2021: On Oct. 21, a historic Private Member’s Bill was introduced into the Legislature by Bill Walker, MPP for Bruce-Grey-Owen Sound. The bill asserted Ontario’s global role as a leader in the supply of medical isotopes to fight
SASKATOON – Iotron Medical Inc. (Iotron) and Canadian Isotope Innovations Corp. (CIIC) are pleased to announce a collaboration to produce the radioisotope copper-67 (Cu-67) for new cancer therapies. This investment will increase the production capacity of the CIIC-operated facilities in
TORONTO – August 24, 2021 – Niagara Energy Products (NEP), a leader in the field of manufacturing radiation shielded containment vessels for isotopes and nuclear contaminated waste, has joined the Canadian Nuclear Isotope Council (CNIC). NEP has a long and
Women in Nuclear (WiN) Canada, an association that has been working to support the objectives of WiN Global by emphasizing and supporting the role that women can and do have in addressing public concerns about nuclear energy and the application
McMaster University and Promation have signed a Memorandum of Understanding (MoU) to work together to bring a new medical isotope technology developed at McMaster to the marketplace. At the center of this collaboration is a new technology for producing lutetium-177
TORONTO – May 12 , 2021 –The Canadian Nuclear Isotope Council (CNIC) and the Local Organizing Committee of the 11th International Conference on Isotopes (11ICI) have entered into a Memorandum of Understanding to co-promote and support the conference’s success in
(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company. Developed
Medical isotope ecosystem directory details tremendous capabilities of Canada’s isotope industry. Today, the Organization of Canadian Nuclear Industries (OCNI) and the Canadian Nuclear Isotope Council (CNIC) released the Canadian Medical Isotope Ecosystem Directory. The directory demonstrates the capabilities of